We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$17B
AUM Growth
-$1.5B
Cap. Flow
-$3.24B
Cap. Flow %
-19.02%
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 27.35%
2 Financials 13.45%
3 Industrials 10.46%
4 Healthcare 10.18%
5 Communication Services 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODI icon
2051
Compass Diversified
CODI
$924M
$254K ﹤0.01%
40,372
CRNC icon
2052
Cerence
CRNC
$389M
$253K ﹤0.01%
24,805
NEWT icon
2053
NewtekOne
NEWT
$378M
$253K ﹤0.01%
22,446
LXU icon
2054
LSB Industries
LXU
$711M
$253K ﹤0.01%
32,456
+3,348
+12% +$22.9K
OFIX icon
2055
Orthofix Medical
OFIX
$415M
$253K ﹤0.01%
22,661
+2,327
+11% +$28.8K
BAND
2056
Bandwidth Inc
BAND
$1.74B
$251K ﹤0.01%
15,796
+1,716
+12% +$23.3K
CCSI icon
2057
Consensus Cloud Solutions
CCSI
$717M
$251K ﹤0.01%
10,887
CAL icon
2058
Caleres
CAL
$461M
$251K ﹤0.01%
20,529
FLGT icon
2059
Fulgent Genetics
FLGT
$513M
$250K ﹤0.01%
12,579
-276
-2% -$5.38K
HTLD icon
2060
Heartland Express
HTLD
$979M
$250K ﹤0.01%
28,911
+3,250
+13% +$27.9K
TSHA icon
2061
Taysha Gene Therapies
TSHA
$1.92B
$250K ﹤0.01%
108,078
+367
+0.3% +$797
CTKB icon
2062
Cytek Biosciences
CTKB
$636M
$249K ﹤0.01%
73,298
+5,567
+8% +$18.6K
PSFE icon
2063
Paysafe
PSFE
$405M
$249K ﹤0.01%
19,708
COFS icon
2064
Choiceone Financial
COFS
$515M
$249K ﹤0.01%
8,665
+4,489
+107% +$127K
BWMN icon
2065
Bowman Consulting
BWMN
$731M
$248K ﹤0.01%
8,630
+700
+9% +$17.3K
PHAT icon
2066
Phathom Pharmaceuticals
PHAT
$743M
$248K ﹤0.01%
25,845
+1,479
+6% +$8.18K
HONE
2067
DELISTED
HarborOne Bancorp
HONE
$247K ﹤0.01%
21,138
-196
-0.9% -$2.14K
BTBT icon
2068
Bit Digital
BTBT
$520M
$246K ﹤0.01%
112,379
+30,746
+38% +$67.9K
KALV
2069
DELISTED
KalVista Pharmaceuticals
KALV
$245K ﹤0.01%
21,688
NEXN
2070
Nexxen International
NEXN
$598M
$245K ﹤0.01%
+23,548
New +$239K
HBCP icon
2071
Home Bancorp
HBCP
$569M
$245K ﹤0.01%
4,734
MAGN
2072
Magnera Corp
MAGN
$433M
$245K ﹤0.01%
+20,291
New +$279K
AMPX icon
2073
Amprius Technologies
AMPX
$1.74B
$245K ﹤0.01%
+58,207
New +$164K
TNGX icon
2074
Tango Therapeutics
TNGX
$4.32B
$244K ﹤0.01%
+47,726
New +$118K
TRVI icon
2075
Trevi Therapeutics
TRVI
$2.59B
$244K ﹤0.01%
44,656

Similar funds

MetLife Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.

  • MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
  • MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
  • MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
  • MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
  • MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
  • MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.